Kovack Advisors, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1728321
FT. LAUDERDALE, FL
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,467,330
-$1,339,421 QoQ
Shares Held
3,286
-46.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kovack Advisors, Inc. holds $5,306,795 across 13 Biotechnology names. VRTX ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
175,232 | $1,633,162 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,286 | $1,467,330 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
741 | $572,526 | |
| 4 | MRNA |
Moderna, Inc.
|
10,380 | $527,304 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,886 | $232,427 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,825 | $209,784 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,104 | $208,711 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
22,208 | $170,335 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,467,330 | 3,286 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,806,751 | 6,191 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $449,211 | 1,147 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $569,856 | 1,280 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $608,933 | 1,256 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $498,139 | 1,237 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $584,605 | 1,257 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $568,088 | 1,212 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $453,540 | 1,085 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $439,441 | 1,080 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $361,301 | 1,039 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $338,889 | 963 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $320,111 | 1,016 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $272,897 | 945 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $249,873 | 863 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $469,180 | 1,665 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $737,501 | 2,826 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $462,258 | 2,105 | Shares | Sole | 2022-01-18 | |
| 2020-12-31 | $258,555 | 1,094 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $439,201 | 1,614 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $429,078 | 1,478 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $335,271 | 1,409 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||